Episodios

  • Breaking the Silence Around Cancer and Firefighters
    Sep 10 2025

    Firefighters sprint into dangerous situations to protect their communities. But what happens when the very act of helping others puts their own lives at risk?

    Dr. Erin Kobetz and Dr. Alberto Caban-Martinez - leaders of the Firefighter Cancer Initiative at Sylvester Comprehensive Cancer Center - pull back the curtain on a health crisis: the elevated cancer risk firefighters face because of toxic exposures on the job.

    Más Menos
    40 m
  • Parkinson's disease: Can AI and stem cells transform treatment?
    Aug 6 2025

    Neurologist Dr. Ihtsham ul Haq reveals how cutting-edge technology is reshaping diagnosis and why stem cell therapies may hold the power to slow, or even reverse, the disease. Discover the breakthroughs, the setbacks and the race to change the future of Parkinson’s.

    Más Menos
    30 m
  • Reprogramming autoimmune diseases: A breakthrough approach
    Jul 9 2025

    Autoimmune diseases like lupus and Type 1 diabetes are notoriously difficult to treat, but what if we could reprogram the immune system instead of turning it off entirely?

    Preeminent immunologist Dr. Thomas Malek dives into the science behind a lab-designed fusion protein that could offer a powerful new path to long-term remission.

    Más Menos
    29 m
  • Medical research at a crossroad: What’s at risk?
    Jun 11 2025

    In this critical moment for academic medicine and scientific discovery, how can we rebuild trust in our institutions and our work? Dr. Elena Fuentes-Afflick, chief scientific officer of the Association of American Medical Colleges (AAMC) and a leading voice in support of research, joined us to tackle challenging questions and provide insight for scientists at all stages of their academic career.

    Más Menos
    30 m
  • The power of 1%: Unlocking disease clues in our DNA
    May 13 2025

    Humans share 99% of their genes but, according to JacobMcCauley, Ph.D., “that one percent can tell us a lot.” The “1%” in genetic studies refers to the miniscule fraction of DNA that differentiates any two individuals but may be the key for understanding disease susceptibility.

    This small variation is leading to significant discoveries.

    Más Menos
    32 m
  • The mind of a spine surgeon: Trust, perception, and more with Dr. Michael Wang
    Apr 16 2025

    Step into the mind of one of neurosurgery’s most influentialvoices: Michael Wang, M.D., M.B.A., a globally recognized spine surgeon and leader of the largest spine fellowship program in the country.

    Dr. Wang and Dean Henri Ford tackle some of the most pressing challenges for spine surgeons: society scrutiny, public perception, patient trust, work-life balance, spiritual weight of the job and more. And for future and current doctors, it’s a conversation worth hearing.

    Más Menos
    30 m
  • Microplastics in reproductive organs & other threats to women’s health
    Mar 5 2025

    Microplastics and their synthetic byproducts pose a majorrisk to humans through inhalation and ingestion. Could these microscopic pollutants play a role in infertility or cancer? Dr. Raveen Syan and her team are determined to find out.

    Dr. Raveen Syan, assistant professor of clinical urology at the Desai Sethi Urology Institute, and Christina Yarborough, a medical student, joined the podcast to discuss a groundbreaking study that will examine how microplastics accumulate in female reproductive tissue and the potential health effects of these toxins.

    In addition to the microplastics study, she shares insights from her research on Pelvic Floor Disorders (PFD), which impact nearly 1 in 4 women in the U.S., significantly affecting their quality of life.

    Despite this prevalence, few studies have investigated the symptom burden among varying demographics and their perspectives on treatment options.

    Más Menos
    32 m
  • AFib is a silent killer. Why diagnosis & treatment need an overhaul
    Feb 4 2025

    Atrial fibrillation leads to stroke, heart failure, sudden death and other health problems for millions worldwide. Yet, despite decades of research, many aspects of AFib care — from diagnosis to treatment — remain outdated.

    Dr. Jeffrey Goldberger joined Inside U Miami Medicine to share how he is improving decades-old models to save lives.

    “I saw two patients in the office within one month of each other. They had no risk factors. They had no hypertension. They had no significant cardiac disease. And they both had strokes,” he said.

    He knew the field needed to evolve.

    Más Menos
    31 m